SBIO vs. CNCR ETF Comparison
Comparison of ALPS Medical Breakthroughs ETF (SBIO) to Loncar Cancer Immunotherapy ETF (CNCR)
SBIO
ALPS Medical Breakthroughs ETF
SBIO Description
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Grade (RS Rating)
Last Trade
$37.19
Average Daily Volume
8,401
83
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$13.32
Average Daily Volume
3,715
67
Performance
| Period | SBIO | CNCR |
|---|---|---|
| 30 Days | -5.42% | -10.65% |
| 60 Days | -4.19% | -14.47% |
| 90 Days | 2.30% | -9.20% |
| 12 Months | 47.72% | 30.29% |
19 Overlapping Holdings
| Symbol | Grade | Weight in SBIO | Weight in CNCR | Overlap | |
|---|---|---|---|---|---|
| ACLX | C | 3.19% | 1.73% | 1.73% | |
| ALLO | F | 0.35% | 1.18% | 0.35% | |
| ARVN | F | 1.06% | 1.39% | 1.06% | |
| AURA | C | 0.3% | 1.38% | 0.3% | |
| DAWN | D | 0.82% | 1.44% | 0.82% | |
| ERAS | C | 0.51% | 1.46% | 0.51% | |
| GERN | C | 1.48% | 1.31% | 1.31% | |
| IDYA | F | 1.53% | 1.07% | 1.07% | |
| IMCR | C | 1.07% | 1.42% | 1.07% | |
| ITOS | F | 0.19% | 0.98% | 0.19% | |
| KURA | F | 0.83% | 1.16% | 0.83% | |
| MRUS | F | 2.21% | 1.33% | 1.33% | |
| RCUS | F | 0.95% | 1.29% | 0.95% | |
| REPL | C | 0.5% | 1.56% | 0.5% | |
| SNDX | F | 0.93% | 1.34% | 0.93% | |
| STRO | F | 0.17% | 1.12% | 0.17% | |
| XNCR | B | 0.98% | 1.66% | 0.98% | |
| YMAB | F | 0.34% | 1.24% | 0.34% | |
| ZNTL | D | 0.17% | 1.25% | 0.17% |
SBIO Overweight 64 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| CORT | B | 3.66% | |
| KRYS | C | 3.39% | |
| RNA | C | 3.29% | |
| ALKS | C | 3.15% | |
| CRNX | B | 2.95% | |
| IMVT | F | 2.66% | |
| DNLI | D | 2.36% | |
| AGIO | C | 2.05% | |
| PTCT | B | 2.02% | |
| XENE | D | 2.01% | |
| VRNA | A | 1.98% | |
| FOLD | F | 1.95% | |
| EWTX | C | 1.92% | |
| ACAD | C | 1.89% | |
| VERA | C | 1.82% | |
| ZLAB | C | 1.79% | |
| VCEL | A | 1.73% | |
| PTGX | D | 1.61% | |
| CGON | F | 1.57% | |
| MIRM | B | 1.47% | |
| KROS | D | 1.4% | |
| LBPH | A | 1.4% | |
| AKRO | C | 1.32% | |
| MNKD | B | 1.26% | |
| IRON | B | 1.21% | |
| GLPG | F | 1.19% | |
| TARS | C | 1.16% | |
| CLDX | D | 1.06% | |
| BCRX | D | 0.99% | |
| NTLA | F | 0.94% | |
| SPRY | C | 0.88% | |
| VRDN | D | 0.84% | |
| AUPH | C | 0.78% | |
| PHVS | D | 0.76% | |
| APLT | B | 0.72% | |
| COGT | D | 0.69% | |
| ETNB | D | 0.57% | |
| LQDA | F | 0.54% | |
| PLRX | D | 0.53% | |
| PRTA | F | 0.52% | |
| IRWD | F | 0.44% | |
| AVXL | B | 0.42% | |
| ANNX | F | 0.4% | |
| MLYS | F | 0.39% | |
| ALT | C | 0.37% | |
| OLMA | F | 0.37% | |
| ANAB | F | 0.36% | |
| FLGT | F | 0.35% | |
| CELC | F | 0.34% | |
| URGN | F | 0.34% | |
| SVRA | F | 0.34% | |
| FULC | F | 0.33% | |
| TBPH | B | 0.32% | |
| FDMT | F | 0.31% | |
| GHRS | B | 0.31% | |
| ARCT | F | 0.31% | |
| ALEC | F | 0.28% | |
| CMPS | F | 0.23% | |
| ACIU | D | 0.22% | |
| VNDA | C | 0.2% | |
| ALDX | D | 0.17% | |
| ENTA | F | 0.14% | |
| INZY | F | 0.12% | |
| HLVX | F | 0.06% |
SBIO Underweight 48 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| GLUE | C | -2.03% | |
| EXEL | B | -1.9% | |
| RVMD | B | -1.84% | |
| BMY | B | -1.72% | |
| ELVN | C | -1.68% | |
| MRSN | C | -1.62% | |
| BPMC | C | -1.58% | |
| KPTI | D | -1.57% | |
| GNLX | D | -1.56% | |
| MGNX | D | -1.55% | |
| HCM | C | -1.54% | |
| SWTX | C | -1.47% | |
| CRBU | D | -1.47% | |
| JANX | C | -1.46% | |
| RXRX | D | -1.39% | |
| SDGR | C | -1.39% | |
| LYEL | F | -1.35% | |
| KYMR | D | -1.32% | |
| RPTX | F | -1.32% | |
| IOVA | F | -1.3% | |
| NRIX | C | -1.29% | |
| FHTX | C | -1.26% | |
| NUVB | C | -1.26% | |
| BNTX | D | -1.25% | |
| MRK | F | -1.24% | |
| BCYC | F | -1.24% | |
| BMEA | F | -1.22% | |
| PGEN | F | -1.2% | |
| CGEM | F | -1.2% | |
| NUVL | D | -1.18% | |
| VOR | D | -1.17% | |
| GMAB | F | -1.17% | |
| TYRA | F | -1.16% | |
| ACRV | F | -1.15% | |
| AUTL | F | -1.13% | |
| LEGN | D | -1.1% | |
| TSVT | F | -1.06% | |
| REGN | F | -1.0% | |
| IPHA | F | -0.98% | |
| SMMT | D | -0.97% | |
| ACET | F | -0.97% | |
| IMRX | F | -0.95% | |
| IMTX | F | -0.93% | |
| RLAY | F | -0.91% | |
| IGMS | F | -0.88% | |
| RAPT | F | -0.88% | |
| FATE | F | -0.87% | |
| PRLD | F | -0.55% |
SBIO: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
